{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T10:15:05Z","timestamp":1783937705742,"version":"3.55.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"4-5","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.autrev.2014.01.033","type":"journal-article","created":{"date-parts":[[2014,1,13]],"date-time":"2014-01-13T21:30:11Z","timestamp":1389648611000},"page":"525-530","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Guillain Barr\u00e9 syndrome and other immune mediated neuropathies: Diagnosis and classification"],"prefix":"10.1016","volume":"13","author":[{"given":"Adi","family":"Hersalis Eldar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joab","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2014.01.033_bb0005","first-page":"1462","article-title":"Sur un syndrome de radiculo-nevrite avec hyperalbuminose du liquide cephalorachidien sans reaction cellulaire. Remarques sur les caracteres cliniques et graphiques desrefl exes tendineux","volume":"28","author":"Guillain","year":"1916","journal-title":"Bull Soc Med Hop Paris"},{"key":"10.1016\/j.autrev.2014.01.033_bb0320","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain-Barr\u00e9 syndrome","volume":"366","author":"Hughes","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2014.01.033_bb0015","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/brain\/awf272","article-title":"Peripheral neuropathies and anti-glycolipid antibodies","volume":"125","author":"Willison","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2014.01.033_bb0020","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(08)70215-1","article-title":"Clinical features, pathogenesis, and treatment of Guillain-Barr\u00e9 syndrome","volume":"7","author":"van Doorn","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2014.01.033_bb0025","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1529-8027.2012.00433.x","article-title":"Recent developments and future directions in Guillain-Barr\u00e9 syndrome","volume":"17 (Suppl.)","author":"Lehmann","year":"2012","journal-title":"J Peripher Nerv Syst"},{"issue":"Suppl.","key":"10.1016\/j.autrev.2014.01.033_bb0030","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain-Barr\u00e9 syndrome","volume":"27","author":"Asbury","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2014.01.033_bb0035","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/ana.410330402","article-title":"Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China","volume":"33","author":"McKhann","year":"1993","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2014.01.033_bb0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ana.410390105","article-title":"Pathology of the motor-sensory axonal Guillain-Barr\u00e9 syndrome","volume":"39","author":"Griffin","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2014.01.033_bb0045","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1056\/NEJM195607122550201","article-title":"An unusual variant of acute idiopathic polyneuritis: syndrome of ophthalmoplegia, ataxia and areflexia","volume":"255","author":"Fisher","year":"1956","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2014.01.033_bb0050","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/bmj.291.6494.535","article-title":"Coma and brain stem areflexia in brain stem encephalitis (Fisher's syndrome) [letter]","volume":"291","author":"Al-Din","year":"1985","journal-title":"Br Med J"},{"key":"10.1016\/j.autrev.2014.01.033_bb0055","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/jnnp.64.1.74","article-title":"An epidemiological study of Guillain-Barr\u00e9 syndrome in South East England","volume":"64","author":"Rees","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2014.01.033_bb0060","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ana.410440512","article-title":"Electrophysiological classification of Guillain-Barr\u00e9 syndrome: clinical associations and outcome","volume":"44","author":"Hadden","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2014.01.033_bb0065","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1212\/WNL.53.3.598","article-title":"Prognostic factors of Guillain-Barr\u00e9 syndrome after intravenous immunoglobulin or plasma exchange","volume":"53","author":"Visser","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2014.01.033_bb0070","first-page":"CD002063","article-title":"Intravenous immunoglobulin for Guillain-Barr\u00e9 syndrome","author":"Hughes","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"8845","key":"10.1016\/j.autrev.2014.01.033_bb0075","first-page":"586","article-title":"Double-blind trial of intravenous methylprednisolone in Guillain-Barr\u00e9 syndrome. Guillain-Barr\u00e9 Syndrome Steroid Trial Group","volume":"341","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2014.01.033_bb0080","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S1474-4422(10)70041-7","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition","volume":"9","author":"Vallat","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2014.01.033_bb0085","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMra041347","article-title":"Chronic inflammatory demyelinating polyneuropathy","volume":"352","author":"Koller","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2014.01.033_bb0090","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1212\/WNL.32.9.958","article-title":"Multifocal demyelinating neuropathy with persistent conduction block","volume":"32","author":"Lewis","year":"1982","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2014.01.033_bb0095","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/(SICI)1097-4598(199905)22:5<560::AID-MUS2>3.0.CO;2-Q","article-title":"Multifocal acquired demyelinating sensory and motor neuropathy: the Lewis-Sumner syndrome","volume":"22","author":"Saperstein","year":"1999","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.autrev.2014.01.033_bb0100","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1212\/WNL.54.3.615","article-title":"Distal acquired demyelinating symmetric neuropathy","volume":"54","author":"Katz","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2014.01.033_bb0105","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1007\/s004150170093","article-title":"Pure motor chronic inflammatory demyelinating polyneuropathy","volume":"248","author":"Sabatelli","year":"2001","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2014.01.033_bb0110","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1136\/jnnp.55.8.677","article-title":"\u201cChronic sensory demyelinating neuropathy\u201d: chronic inflammatory demyelinating polyneuropathy presenting as a pure sensory neuropathy","volume":"55","author":"Oh","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2014.01.033_bb0115","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1212\/01.WNL.0000142507.12763.58","article-title":"Chronic immune sensory polyradiculopathy: a possibly treatable sensory ataxia","volume":"63","author":"Sinnreich","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2014.01.033_bb0120","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(00)02109-7","article-title":"Atypical varieties of chronic infl amatory demyelinating neuropathies","volume":"355","author":"Dyck","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2014.01.033_bb0125","first-page":"621","article-title":"Chronic inflammatory polyradiculoneuropathy","volume":"50","author":"Dyck","year":"1975","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.autrev.2014.01.033_bb0130","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/mus.22038","article-title":"Review of the evolution of electrodiagnostic criteria for chronic inflammatory demyelinating polyradiculopathy","volume":"43","author":"Bromberg","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.autrev.2014.01.033_bb0135","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrneurol.2011.121","article-title":"Advances in the diagnosis, pathogenesis and treatment of CIDP","volume":"7","author":"Dalakas","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.autrev.2014.01.033_bb0140","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00234-010-0684-7","article-title":"Brachial and lumbar plexuses in chronic inflammatory demyelinating polyradiculoneuropathy: MRI assessment including apparent diffusion coefficient","volume":"53","author":"Adachi","year":"2011","journal-title":"Neuroradiology"},{"key":"10.1016\/j.autrev.2014.01.033_bb0145","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/ana.410110205","article-title":"Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment","volume":"11","author":"Dyck","year":"1982","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2014.01.033_bb0150","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1212\/WNL.48.2.321","article-title":"Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy","volume":"48","author":"Gorson","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2014.01.033_bb0160","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1085-9489.2005.10302.x","volume":"10","year":"2005","journal-title":"J Peripher Nerv Syst"},{"issue":"6 Suppl. 5","key":"10.1016\/j.autrev.2014.01.033_bb0170","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1212\/WNL.51.6_Suppl_5.S16","article-title":"Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin","volume":"51","author":"Hahn","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2014.01.033_bb0175","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/BF00868527","article-title":"A novel trial design to study the effect of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"243","author":"Thompson","year":"1996","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2014.01.033_bb0185","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/ana.410360607","article-title":"A plasma exchange versus immune globulin infusion trial in chronic infl amatory demyelinating polyradiculoneuropathy","volume":"36","author":"Dyck","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2014.01.033_bb0190","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/ana.1088","article-title":"Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"50","author":"Hughes","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2014.01.033_bb0205","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1056\/NEJM198602203140801","article-title":"Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"314","author":"Dyck","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2014.01.033_bb0210","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/brain\/119.4.1055","article-title":"Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A doubleblind, sham-controlled, cross-over study","volume":"119","author":"Hahn","year":"1996","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2014.01.033_bb0215","first-page":"CD003280","article-title":"Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy","volume":"4","author":"Hughes","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.autrev.2014.01.033_bb0220","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ana.410240113","article-title":"A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside","volume":"24","author":"Pestronk","year":"1988","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2014.01.033_bb0225","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0165-5728(01)00266-1","article-title":"Multifocal motor neuropathy","volume":"115","author":"Nobile-Orazio","year":"2001","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2014.01.033_bb0230","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/mus.20296","article-title":"Multifocal motor neuropathy: current concepts and controversies","volume":"31","author":"Nobile-Orazio","year":"2005","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.autrev.2014.01.033_bb0235","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1529-8027.2010.00290.x","volume":"15","author":"Joint Task Force of the EFNS and the PNS","year":"2010","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.autrev.2014.01.033_bb0240","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/mus.880140913","article-title":"Conduction block in clinical practice","volume":"14","author":"Cornblath","year":"1991","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.autrev.2014.01.033_bb0245","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ana.410240113","article-title":"A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside","volume":"24","author":"Pestronk","year":"1988","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2014.01.033_bb0250","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1212\/WNL.45.8.1570","article-title":"The diagnostic value of GM1 antibodies in motor neuron disorders and neuropathies: a meta-analysis","volume":"45","author":"van Schaik","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2014.01.033_bb0255","first-page":"CD004429","article-title":"Intravenous immunoglobuline for multifocal motor neuropathy","volume":"2","author":"van Schaik","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.autrev.2014.01.033_bb0260","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1212\/WNL.48.4.1135","article-title":"Pulsed high-dose dexamethasone is not effective in patients with multifocal motor neuropathy","volume":"48","author":"Van den Berg","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2014.01.033_bb0265","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1212\/WNL.50.5.1480","article-title":"Deterioration of multifocal motor neuropathy after plasma exchange","volume":"50","author":"Carpo","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2014.01.033_bb0270","doi-asserted-by":"crossref","first-page":"311e22","DOI":"10.1097\/00005792-198007000-00006","article-title":"Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature","volume":"59","author":"Bardwick","year":"1980","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2014.01.033_bb0280","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1182\/blood-2002-07-2299","article-title":"POEMS syndrome: definitions and long-term outcome","volume":"101","author":"Dispenzieri","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2014.01.033_bb0285","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(96)91261-1","article-title":"Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome","volume":"347","author":"Watanabe","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2014.01.033_bb0290","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.blre.2007.07.004","article-title":"POEMS syndrome","volume":"21","author":"Dispenzieri","year":"2007","journal-title":"Blood Rev"},{"key":"10.1016\/j.autrev.2014.01.033_bb0295","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1136\/jnnp.2010.205369","article-title":"POEMS syndrome with Guillain Barre syndrome like acute onset: a case report and review of neurological progression in 30 cases","volume":"82","author":"Isose","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1016\/j.autrev.2014.01.033_bb0310","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/jnnp-2011-301706","article-title":"Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathy","volume":"83","author":"Nasu","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1016\/j.autrev.2014.01.033_bb0315","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006828.pub3","article-title":"Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome","author":"Kuwabara","year":"2012","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997214000457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997214000457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T12:30:56Z","timestamp":1565094656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997214000457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":55,"journal-issue":{"issue":"4-5","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S1568997214000457"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2014.01.033","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guillain Barr\u00e9 syndrome and other immune mediated neuropathies: Diagnosis and classification","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2014.01.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}